PCSA
Processa Pharmaceuticals, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
—
Largest filed tie
—
13F top-10 QoQ
Top fund weight
—
Processa Pharmaceuticals, Inc.
Expected move
InputsNext report
Last report
—
Largest filed tie
—
13F top-10 QoQ
Top fund weight
—
1.93
−0.01 · −0.52%
+10.45%
shares held · 8 largest managers
No filed income statement.
No reported quarters.
No open-interest data.
Bar = avg |move| to ±9% · tick = ±6.0% avg day · ×base = |move| ÷ ±6.0% · min 6 releases
| Quarter | Reported | EPS | Consensus |
|---|---|---|---|
| Q2 FY26 | — | -1.19 | — |
| Q1 FY26 | — | -1.29 | — |
| Q3 FY25 | — | -0.07 | — |
Source: filed financials
Expected move
No implied move.
No linked exposure.